BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12167664)

  • 1. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin.
    Dan HC; Sun M; Yang L; Feldman RI; Sui XM; Ou CC; Nellist M; Yeung RS; Halley DJ; Nicosia SV; Pledger WJ; Cheng JQ
    J Biol Chem; 2002 Sep; 277(38):35364-70. PubMed ID: 12167664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
    Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin.
    Tee AR; Anjum R; Blenis J
    J Biol Chem; 2003 Sep; 278(39):37288-96. PubMed ID: 12867426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour suppressors hamartin and tuberin: intracellular signalling.
    Krymskaya VP
    Cell Signal; 2003 Aug; 15(8):729-39. PubMed ID: 12781866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.
    Manning BD; Tee AR; Logsdon MN; Blenis J; Cantley LC
    Mol Cell; 2002 Jul; 10(1):151-62. PubMed ID: 12150915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
    Aicher LD; Campbell JS; Yeung RS
    J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
    Tee AR; Fingar DC; Manning BD; Kwiatkowski DJ; Cantley LC; Blenis J
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13571-6. PubMed ID: 12271141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tuberin-hamartin complex negatively regulates beta-catenin signaling activity.
    Mak BC; Takemaru K; Kenerson HL; Moon RT; Yeung RS
    J Biol Chem; 2003 Feb; 278(8):5947-51. PubMed ID: 12511557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
    Hodges AK; Li S; Maynard J; Parry L; Braverman R; Cheadle JP; DeClue JE; Sampson JR
    Hum Mol Genet; 2001 Dec; 10(25):2899-905. PubMed ID: 11741833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
    Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ
    Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy.
    Valianou M; Cox AM; Pichette B; Hartley S; Paladhi UR; Astrinidis A
    Cell Cycle; 2015; 14(3):399-407. PubMed ID: 25565629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling.
    Manning BD; Cantley LC
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):573-8. PubMed ID: 12773158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B.
    Astrinidis A; Senapedis W; Coleman TR; Henske EP
    J Biol Chem; 2003 Dec; 278(51):51372-9. PubMed ID: 14551205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.
    Nellist M; Goedbloed MA; Halley DJ
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):587-91. PubMed ID: 12773161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin.
    Nellist M; van Slegtenhorst MA; Goedbloed M; van den Ouweland AM; Halley DJ; van der Sluijs P
    J Biol Chem; 1999 Dec; 274(50):35647-52. PubMed ID: 10585443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin.
    Shumway SD; Li Y; Xiong Y
    J Biol Chem; 2003 Jan; 278(4):2089-92. PubMed ID: 12468542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions.
    Han S; Santos TM; Puga A; Roy J; Thiele EA; McCollin M; Stemmer-Rachamimov A; Ramesh V
    Cancer Res; 2004 Feb; 64(3):812-6. PubMed ID: 14871804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2.
    Rosner M; Hengstschläger M
    J Biol Chem; 2004 Nov; 279(47):48707-15. PubMed ID: 15355997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.
    Inoki K; Li Y; Zhu T; Wu J; Guan KL
    Nat Cell Biol; 2002 Sep; 4(9):648-57. PubMed ID: 12172553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.